nodes	percent_of_prediction	percent_of_DWPC	metapath
Pregabalin—Thyroid disorder—Octreotide—thymus cancer	0.0294	0.0341	CcSEcCtD
Pregabalin—Glucose tolerance decreased—Octreotide—thymus cancer	0.024	0.0279	CcSEcCtD
Pregabalin—Adrenal insufficiency—Octreotide—thymus cancer	0.023	0.0267	CcSEcCtD
Pregabalin—CACNA2D2—neck—thymus cancer	0.0197	0.144	CbGeAlD
Pregabalin—Abnormal faeces—Octreotide—thymus cancer	0.0169	0.0196	CcSEcCtD
Pregabalin—Breast neoplasm—Octreotide—thymus cancer	0.016	0.0185	CcSEcCtD
Pregabalin—Hepatic steatosis—Octreotide—thymus cancer	0.016	0.0185	CcSEcCtD
Pregabalin—SLC1A1—pituitary gland—thymus cancer	0.0151	0.11	CbGeAlD
Pregabalin—Goitre—Octreotide—thymus cancer	0.0135	0.0157	CcSEcCtD
Pregabalin—SLC1A1—thyroid gland—thymus cancer	0.013	0.0948	CbGeAlD
Pregabalin—Rectal tenesmus—Octreotide—thymus cancer	0.0129	0.015	CcSEcCtD
Pregabalin—Varicose vein—Octreotide—thymus cancer	0.0129	0.015	CcSEcCtD
Pregabalin—Hypochromic anaemia—Octreotide—thymus cancer	0.0124	0.0144	CcSEcCtD
Pregabalin—SLC1A1—lung—thymus cancer	0.0118	0.0861	CbGeAlD
Pregabalin—VIIth nerve paralysis—Octreotide—thymus cancer	0.0118	0.0136	CcSEcCtD
Pregabalin—Prostatic disorder—Octreotide—thymus cancer	0.0113	0.0132	CcSEcCtD
Pregabalin—CACNA2D2—cardiac atrium—thymus cancer	0.0111	0.0811	CbGeAlD
Pregabalin—CACNA2D2—pituitary gland—thymus cancer	0.0109	0.0793	CbGeAlD
Pregabalin—Ulcerative stomatitis—Octreotide—thymus cancer	0.0104	0.0121	CcSEcCtD
Pregabalin—Hernia—Octreotide—thymus cancer	0.0103	0.0119	CcSEcCtD
Pregabalin—Proctalgia—Octreotide—thymus cancer	0.0103	0.0119	CcSEcCtD
Pregabalin—Rectal disorder—Octreotide—thymus cancer	0.00984	0.0114	CcSEcCtD
Pregabalin—Sinus bradycardia—Octreotide—thymus cancer	0.00984	0.0114	CcSEcCtD
Pregabalin—CACNA2D2—thyroid gland—thymus cancer	0.00937	0.0683	CbGeAlD
Pregabalin—Renal pain—Octreotide—thymus cancer	0.00917	0.0106	CcSEcCtD
Pregabalin—Creatine phosphokinase increased—Octreotide—thymus cancer	0.00917	0.0106	CcSEcCtD
Pregabalin—Anorectal disorder—Octreotide—thymus cancer	0.00917	0.0106	CcSEcCtD
Pregabalin—Ear disorder—Octreotide—thymus cancer	0.00894	0.0104	CcSEcCtD
Pregabalin—Anorectal discomfort—Octreotide—thymus cancer	0.00882	0.0102	CcSEcCtD
Pregabalin—CACNA2D2—lung—thymus cancer	0.00851	0.0621	CbGeAlD
Pregabalin—Cholecystitis—Octreotide—thymus cancer	0.0084	0.00973	CcSEcCtD
Pregabalin—SLC1A1—lymph node—thymus cancer	0.00808	0.0589	CbGeAlD
Pregabalin—Cholelithiasis—Octreotide—thymus cancer	0.00776	0.00899	CcSEcCtD
Pregabalin—Hypothyroidism—Octreotide—thymus cancer	0.00751	0.00871	CcSEcCtD
Pregabalin—Nail disorder—Octreotide—thymus cancer	0.00744	0.00862	CcSEcCtD
Pregabalin—Galactorrhoea—Octreotide—thymus cancer	0.00744	0.00862	CcSEcCtD
Pregabalin—Peptic ulcer—Octreotide—thymus cancer	0.00722	0.00836	CcSEcCtD
Pregabalin—Menstrual disorder—Octreotide—thymus cancer	0.00708	0.0082	CcSEcCtD
Pregabalin—Paranoia—Octreotide—thymus cancer	0.00708	0.0082	CcSEcCtD
Pregabalin—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.00708	0.0082	CcSEcCtD
Pregabalin—Intestinal obstruction—Octreotide—thymus cancer	0.00708	0.0082	CcSEcCtD
Pregabalin—Blood creatine phosphokinase increased—Octreotide—thymus cancer	0.00701	0.00812	CcSEcCtD
Pregabalin—Neuralgia—Octreotide—thymus cancer	0.00694	0.00805	CcSEcCtD
Pregabalin—Burning sensation—Octreotide—thymus cancer	0.00694	0.00805	CcSEcCtD
Pregabalin—CACNA2D1—bone marrow—thymus cancer	0.00676	0.0493	CbGeAlD
Pregabalin—Metrorrhagia—Octreotide—thymus cancer	0.00675	0.00783	CcSEcCtD
Pregabalin—CACNA2D1—thyroid gland—thymus cancer	0.00674	0.0491	CbGeAlD
Pregabalin—Neuritis—Octreotide—thymus cancer	0.00646	0.00749	CcSEcCtD
Pregabalin—Herpes zoster—Octreotide—thymus cancer	0.00641	0.00742	CcSEcCtD
Pregabalin—Otitis media—Octreotide—thymus cancer	0.0062	0.00718	CcSEcCtD
Pregabalin—Coagulopathy—Octreotide—thymus cancer	0.0062	0.00718	CcSEcCtD
Pregabalin—CACNA2D1—lung—thymus cancer	0.00612	0.0446	CbGeAlD
Pregabalin—Nephrolithiasis—Octreotide—thymus cancer	0.006	0.00695	CcSEcCtD
Pregabalin—Injection site pain—Octreotide—thymus cancer	0.00591	0.00685	CcSEcCtD
Pregabalin—Petechiae—Octreotide—thymus cancer	0.00586	0.0068	CcSEcCtD
Pregabalin—CACNA2D2—lymph node—thymus cancer	0.00582	0.0424	CbGeAlD
Pregabalin—Neoplasm malignant—Octreotide—thymus cancer	0.00565	0.00655	CcSEcCtD
Pregabalin—Breast pain—Octreotide—thymus cancer	0.00553	0.00641	CcSEcCtD
Pregabalin—Jaundice cholestatic—Octreotide—thymus cancer	0.00549	0.00636	CcSEcCtD
Pregabalin—Amenorrhoea—Octreotide—thymus cancer	0.00549	0.00636	CcSEcCtD
Pregabalin—Rectal haemorrhage—Octreotide—thymus cancer	0.00534	0.00619	CcSEcCtD
Pregabalin—Viral infection—Octreotide—thymus cancer	0.00534	0.00619	CcSEcCtD
Pregabalin—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0053	0.00615	CcSEcCtD
Pregabalin—Arthropathy—Octreotide—thymus cancer	0.0053	0.00615	CcSEcCtD
Pregabalin—Cellulitis—Octreotide—thymus cancer	0.0053	0.00615	CcSEcCtD
Pregabalin—Herpes simplex—Octreotide—thymus cancer	0.00523	0.00607	CcSEcCtD
Pregabalin—Muscle twitching—Octreotide—thymus cancer	0.00491	0.00569	CcSEcCtD
Pregabalin—Phosphatase alkaline increased—Octreotide—thymus cancer	0.00482	0.00559	CcSEcCtD
Pregabalin—Vaginal inflammation—Octreotide—thymus cancer	0.00482	0.00559	CcSEcCtD
Pregabalin—Injection site reaction—Octreotide—thymus cancer	0.0048	0.00556	CcSEcCtD
Pregabalin—Hyperkalaemia—Octreotide—thymus cancer	0.00474	0.00549	CcSEcCtD
Pregabalin—Eructation—Octreotide—thymus cancer	0.00474	0.00549	CcSEcCtD
Pregabalin—Cystitis noninfective—Octreotide—thymus cancer	0.00471	0.00546	CcSEcCtD
Pregabalin—Cystitis—Octreotide—thymus cancer	0.00466	0.0054	CcSEcCtD
Pregabalin—Candida infection—Octreotide—thymus cancer	0.00461	0.00534	CcSEcCtD
Pregabalin—Vaginal infection—Octreotide—thymus cancer	0.00455	0.00528	CcSEcCtD
Pregabalin—Neuropathy—Octreotide—thymus cancer	0.00453	0.00525	CcSEcCtD
Pregabalin—Cramps of lower extremities—Octreotide—thymus cancer	0.00443	0.00514	CcSEcCtD
Pregabalin—Mouth ulceration—Octreotide—thymus cancer	0.00436	0.00505	CcSEcCtD
Pregabalin—Urine output increased—Octreotide—thymus cancer	0.00436	0.00505	CcSEcCtD
Pregabalin—Bladder pain—Octreotide—thymus cancer	0.00436	0.00505	CcSEcCtD
Pregabalin—Gynaecomastia—Octreotide—thymus cancer	0.00432	0.005	CcSEcCtD
Pregabalin—Hyperkinesia—Octreotide—thymus cancer	0.00421	0.00488	CcSEcCtD
Pregabalin—CACNA2D1—lymph node—thymus cancer	0.00419	0.0305	CbGeAlD
Pregabalin—Phlebitis—Octreotide—thymus cancer	0.00406	0.00471	CcSEcCtD
Pregabalin—Sleep disorder—Octreotide—thymus cancer	0.00404	0.00469	CcSEcCtD
Pregabalin—Thrombophlebitis—Octreotide—thymus cancer	0.00404	0.00469	CcSEcCtD
Pregabalin—Blood alkaline phosphatase increased—Octreotide—thymus cancer	0.00403	0.00467	CcSEcCtD
Pregabalin—Diabetes mellitus—Octreotide—thymus cancer	0.00403	0.00467	CcSEcCtD
Pregabalin—Polyuria—Octreotide—thymus cancer	0.00399	0.00462	CcSEcCtD
Pregabalin—Gastroenteritis—Octreotide—thymus cancer	0.00395	0.00458	CcSEcCtD
Pregabalin—Deafness—Octreotide—thymus cancer	0.00391	0.00454	CcSEcCtD
Pregabalin—Cardiac failure congestive—Octreotide—thymus cancer	0.00386	0.00447	CcSEcCtD
Pregabalin—Nasal congestion—Octreotide—thymus cancer	0.00384	0.00445	CcSEcCtD
Pregabalin—Injury—Octreotide—thymus cancer	0.00381	0.00442	CcSEcCtD
Pregabalin—Hot flush—Octreotide—thymus cancer	0.00374	0.00434	CcSEcCtD
Pregabalin—Amnesia—Octreotide—thymus cancer	0.00373	0.00432	CcSEcCtD
Pregabalin—Menopausal symptoms—Octreotide—thymus cancer	0.00371	0.0043	CcSEcCtD
Pregabalin—Visual disturbance—Octreotide—thymus cancer	0.00369	0.00428	CcSEcCtD
Pregabalin—Anaphylactoid reaction—Octreotide—thymus cancer	0.00362	0.00419	CcSEcCtD
Pregabalin—Arthritis—Octreotide—thymus cancer	0.0036	0.00418	CcSEcCtD
Pregabalin—Hypoglycaemia—Octreotide—thymus cancer	0.00359	0.00416	CcSEcCtD
Pregabalin—Pain in extremity—Octreotide—thymus cancer	0.0035	0.00406	CcSEcCtD
Pregabalin—Osteoarthritis—Octreotide—thymus cancer	0.0035	0.00406	CcSEcCtD
Pregabalin—Gastrointestinal haemorrhage—Octreotide—thymus cancer	0.0035	0.00406	CcSEcCtD
Pregabalin—Psychotic disorder—Octreotide—thymus cancer	0.00342	0.00396	CcSEcCtD
Pregabalin—Irritability—Octreotide—thymus cancer	0.00334	0.00387	CcSEcCtD
Pregabalin—Dehydration—Octreotide—thymus cancer	0.00326	0.00377	CcSEcCtD
Pregabalin—Dry skin—Octreotide—thymus cancer	0.00321	0.00372	CcSEcCtD
Pregabalin—Cramp muscle—Octreotide—thymus cancer	0.00315	0.00365	CcSEcCtD
Pregabalin—Nasopharyngitis—Octreotide—thymus cancer	0.00313	0.00363	CcSEcCtD
Pregabalin—Gastritis—Octreotide—thymus cancer	0.0031	0.00359	CcSEcCtD
Pregabalin—Muscular weakness—Octreotide—thymus cancer	0.00309	0.00358	CcSEcCtD
Pregabalin—Abdominal distension—Octreotide—thymus cancer	0.00305	0.00353	CcSEcCtD
Pregabalin—Asthma—Octreotide—thymus cancer	0.00303	0.00351	CcSEcCtD
Pregabalin—Influenza—Octreotide—thymus cancer	0.00303	0.00351	CcSEcCtD
Pregabalin—Pancreatitis—Octreotide—thymus cancer	0.00297	0.00344	CcSEcCtD
Pregabalin—Bronchitis—Octreotide—thymus cancer	0.00291	0.00337	CcSEcCtD
Pregabalin—Dysuria—Octreotide—thymus cancer	0.00283	0.00328	CcSEcCtD
Pregabalin—Pollakiuria—Octreotide—thymus cancer	0.0028	0.00324	CcSEcCtD
Pregabalin—Weight increased—Octreotide—thymus cancer	0.00275	0.00319	CcSEcCtD
Pregabalin—Weight decreased—Octreotide—thymus cancer	0.00274	0.00317	CcSEcCtD
Pregabalin—Hyperglycaemia—Octreotide—thymus cancer	0.00273	0.00316	CcSEcCtD
Pregabalin—Pneumonia—Octreotide—thymus cancer	0.00271	0.00315	CcSEcCtD
Pregabalin—Depression—Octreotide—thymus cancer	0.00269	0.00312	CcSEcCtD
Pregabalin—Neuropathy peripheral—Octreotide—thymus cancer	0.00265	0.00307	CcSEcCtD
Pregabalin—Jaundice—Octreotide—thymus cancer	0.00263	0.00305	CcSEcCtD
Pregabalin—Conjunctivitis—Octreotide—thymus cancer	0.00262	0.00304	CcSEcCtD
Pregabalin—Urinary tract infection—Octreotide—thymus cancer	0.00262	0.00304	CcSEcCtD
Pregabalin—Haematuria—Octreotide—thymus cancer	0.00257	0.00298	CcSEcCtD
Pregabalin—Epistaxis—Octreotide—thymus cancer	0.00255	0.00295	CcSEcCtD
Pregabalin—Sinusitis—Octreotide—thymus cancer	0.00253	0.00293	CcSEcCtD
Pregabalin—Bradycardia—Octreotide—thymus cancer	0.00247	0.00286	CcSEcCtD
Pregabalin—Rhinitis—Octreotide—thymus cancer	0.00243	0.00281	CcSEcCtD
Pregabalin—Hepatitis—Octreotide—thymus cancer	0.00242	0.00281	CcSEcCtD
Pregabalin—Hypoaesthesia—Octreotide—thymus cancer	0.00241	0.00279	CcSEcCtD
Pregabalin—Pharyngitis—Octreotide—thymus cancer	0.0024	0.00279	CcSEcCtD
Pregabalin—Oedema peripheral—Octreotide—thymus cancer	0.00239	0.00277	CcSEcCtD
Pregabalin—Visual impairment—Octreotide—thymus cancer	0.00233	0.00271	CcSEcCtD
Pregabalin—Tinnitus—Octreotide—thymus cancer	0.00226	0.00262	CcSEcCtD
Pregabalin—Flushing—Octreotide—thymus cancer	0.00225	0.00261	CcSEcCtD
Pregabalin—Cardiac disorder—Octreotide—thymus cancer	0.00225	0.00261	CcSEcCtD
Pregabalin—Immune system disorder—Octreotide—thymus cancer	0.00219	0.00254	CcSEcCtD
Pregabalin—Arrhythmia—Octreotide—thymus cancer	0.00216	0.00251	CcSEcCtD
Pregabalin—Alopecia—Octreotide—thymus cancer	0.00214	0.00248	CcSEcCtD
Pregabalin—Mental disorder—Octreotide—thymus cancer	0.00212	0.00246	CcSEcCtD
Pregabalin—Malnutrition—Octreotide—thymus cancer	0.00211	0.00244	CcSEcCtD
Pregabalin—Flatulence—Octreotide—thymus cancer	0.00208	0.00241	CcSEcCtD
Pregabalin—Tension—Octreotide—thymus cancer	0.00207	0.0024	CcSEcCtD
Pregabalin—Nervousness—Octreotide—thymus cancer	0.00205	0.00237	CcSEcCtD
Pregabalin—Back pain—Octreotide—thymus cancer	0.00204	0.00236	CcSEcCtD
Pregabalin—Muscle spasms—Octreotide—thymus cancer	0.00203	0.00235	CcSEcCtD
Pregabalin—Vision blurred—Octreotide—thymus cancer	0.00199	0.0023	CcSEcCtD
Pregabalin—Tremor—Octreotide—thymus cancer	0.00198	0.00229	CcSEcCtD
Pregabalin—Ill-defined disorder—Octreotide—thymus cancer	0.00196	0.00227	CcSEcCtD
Pregabalin—Anaemia—Octreotide—thymus cancer	0.00195	0.00226	CcSEcCtD
Pregabalin—Agitation—Octreotide—thymus cancer	0.00194	0.00225	CcSEcCtD
Pregabalin—Malaise—Octreotide—thymus cancer	0.0019	0.0022	CcSEcCtD
Pregabalin—Vertigo—Octreotide—thymus cancer	0.00189	0.0022	CcSEcCtD
Pregabalin—Syncope—Octreotide—thymus cancer	0.00189	0.00219	CcSEcCtD
Pregabalin—Palpitations—Octreotide—thymus cancer	0.00186	0.00216	CcSEcCtD
Pregabalin—Loss of consciousness—Octreotide—thymus cancer	0.00185	0.00215	CcSEcCtD
Pregabalin—Cough—Octreotide—thymus cancer	0.00184	0.00213	CcSEcCtD
Pregabalin—Convulsion—Octreotide—thymus cancer	0.00183	0.00212	CcSEcCtD
Pregabalin—Hypertension—Octreotide—thymus cancer	0.00182	0.00211	CcSEcCtD
Pregabalin—Arthralgia—Octreotide—thymus cancer	0.0018	0.00208	CcSEcCtD
Pregabalin—Chest pain—Octreotide—thymus cancer	0.0018	0.00208	CcSEcCtD
Pregabalin—Myalgia—Octreotide—thymus cancer	0.0018	0.00208	CcSEcCtD
Pregabalin—Anxiety—Octreotide—thymus cancer	0.00179	0.00207	CcSEcCtD
Pregabalin—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00178	0.00207	CcSEcCtD
Pregabalin—Discomfort—Octreotide—thymus cancer	0.00177	0.00206	CcSEcCtD
Pregabalin—Dry mouth—Octreotide—thymus cancer	0.00176	0.00203	CcSEcCtD
Pregabalin—Oedema—Octreotide—thymus cancer	0.00172	0.00199	CcSEcCtD
Pregabalin—Anaphylactic shock—Octreotide—thymus cancer	0.00172	0.00199	CcSEcCtD
Pregabalin—Infection—Octreotide—thymus cancer	0.00171	0.00198	CcSEcCtD
Pregabalin—Shock—Octreotide—thymus cancer	0.00169	0.00196	CcSEcCtD
Pregabalin—Nervous system disorder—Octreotide—thymus cancer	0.00169	0.00196	CcSEcCtD
Pregabalin—Thrombocytopenia—Octreotide—thymus cancer	0.00169	0.00195	CcSEcCtD
Pregabalin—Tachycardia—Octreotide—thymus cancer	0.00168	0.00195	CcSEcCtD
Pregabalin—Skin disorder—Octreotide—thymus cancer	0.00167	0.00194	CcSEcCtD
Pregabalin—Hyperhidrosis—Octreotide—thymus cancer	0.00166	0.00193	CcSEcCtD
Pregabalin—Anorexia—Octreotide—thymus cancer	0.00164	0.0019	CcSEcCtD
Pregabalin—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00157	0.00182	CcSEcCtD
Pregabalin—Insomnia—Octreotide—thymus cancer	0.00156	0.0018	CcSEcCtD
Pregabalin—Paraesthesia—Octreotide—thymus cancer	0.00155	0.00179	CcSEcCtD
Pregabalin—Dyspnoea—Octreotide—thymus cancer	0.00153	0.00178	CcSEcCtD
Pregabalin—Somnolence—Octreotide—thymus cancer	0.00153	0.00177	CcSEcCtD
Pregabalin—Decreased appetite—Octreotide—thymus cancer	0.0015	0.00173	CcSEcCtD
Pregabalin—Gastrointestinal disorder—Octreotide—thymus cancer	0.00149	0.00172	CcSEcCtD
Pregabalin—Fatigue—Octreotide—thymus cancer	0.00148	0.00172	CcSEcCtD
Pregabalin—Constipation—Octreotide—thymus cancer	0.00147	0.00171	CcSEcCtD
Pregabalin—Pain—Octreotide—thymus cancer	0.00147	0.00171	CcSEcCtD
Pregabalin—Feeling abnormal—Octreotide—thymus cancer	0.00142	0.00164	CcSEcCtD
Pregabalin—Gastrointestinal pain—Octreotide—thymus cancer	0.00141	0.00163	CcSEcCtD
Pregabalin—Urticaria—Octreotide—thymus cancer	0.00137	0.00158	CcSEcCtD
Pregabalin—Abdominal pain—Octreotide—thymus cancer	0.00136	0.00158	CcSEcCtD
Pregabalin—Body temperature increased—Octreotide—thymus cancer	0.00136	0.00158	CcSEcCtD
Pregabalin—Hypersensitivity—Octreotide—thymus cancer	0.00127	0.00147	CcSEcCtD
Pregabalin—Asthenia—Octreotide—thymus cancer	0.00123	0.00143	CcSEcCtD
Pregabalin—Pruritus—Octreotide—thymus cancer	0.00122	0.00141	CcSEcCtD
Pregabalin—Diarrhoea—Octreotide—thymus cancer	0.00118	0.00136	CcSEcCtD
Pregabalin—Dizziness—Octreotide—thymus cancer	0.00114	0.00132	CcSEcCtD
Pregabalin—Vomiting—Octreotide—thymus cancer	0.00109	0.00127	CcSEcCtD
Pregabalin—Rash—Octreotide—thymus cancer	0.00109	0.00126	CcSEcCtD
Pregabalin—Dermatitis—Octreotide—thymus cancer	0.00108	0.00126	CcSEcCtD
Pregabalin—Headache—Octreotide—thymus cancer	0.00108	0.00125	CcSEcCtD
Pregabalin—Nausea—Octreotide—thymus cancer	0.00102	0.00118	CcSEcCtD
